Literature DB >> 8426432

Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis.

S R Khan1, P N Shevock, R L Hackett.   

Abstract

We studied the effect of oral administration of magnesium oxide (MgO) on calcium oxalate (CaOx) nephrolithiasis in rats. Nephrolithiasis was induced by administration of 1.0% ethylene glycol (EG) in drinking water. Magnesium oxide was given mixed with food at 500 mg./100 g. rat chow. Dispensation of MgO resulted in a significant increase of urinary pH and a modest increase in urinary excretion of citrate. Urinary excretion of oxalate started to decline by day 14 and was significantly reduced on days 21 and 28. All rats receiving EG displayed crystalluria. From the group receiving EG only, 3 of 4 rats sacrificed on day 15 and 2 of 4 rats sacrificed on day 29 had CaOx crystal deposits in their kidneys. None of the 8 rats who received both EG and MgO had CaOx nephrolithiasis. Thus our findings indicate that dispensation of magnesium as MgO can be beneficial against calcium oxalate nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426432     DOI: 10.1016/s0022-5347(17)36106-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  [Evidence-based pharmacological metaphylaxis of stone disease].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

2.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

3.  Effect of magnesium on calcium and oxalate ion binding.

Authors:  Julie M Riley; Hyunjin Kim; Timothy D Averch; Hyung J Kim
Journal:  J Endourol       Date:  2013-10-15       Impact factor: 2.942

Review 4.  [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium].

Authors:  T Knoll; T Bach; U Humke; A Neisius; R Stein; M Schönthaler; G Wendt-Nordahl
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

5.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model.

Authors:  Orhan Tanriverdi; Dilek Telci; Mustafa Aydin; Işın Dogan Ekici; Cengiz Miroglu; Kemal Sarıca
Journal:  Urol Res       Date:  2011-05-24

6.  How do stones form? Is unification of theories on stone formation possible?

Authors:  Victoria Y Bird; Saeed R Khan
Journal:  Arch Esp Urol       Date:  2017-01       Impact factor: 0.436

Review 7.  Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.

Authors:  M Straub; W L Strohmaier; W Berg; B Beck; B Hoppe; N Laube; S Lahme; M Schmidt; A Hesse; K U Koehrmann
Journal:  World J Urol       Date:  2005-11-29       Impact factor: 4.226

8.  Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria.

Authors:  Kemal Sarica; Ahmet Erbagci; Faruk Yağci; Kemal Bakir; Sakip Erturhan; Ramazan Uçak
Journal:  Urol Res       Date:  2004-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.